Biodegradable PLGA-b-PEG Nanoparticles Induce T Helper 2 (Th2) Immune Responses and Sustained Antibody Titers via TLR9 Stimulation
Open Access
Abstract
Sustained immune responses, particularly antibody responses, are key for protection against many endemic infectious diseases. Antibody responses are often accompanied by T helper (Th) cell immunity. Herein we study small biodegradable poly (ethylene glycol)-b-poly (lactic-co-glycolic acid) nanoparticles (PEG-b-PLGA NPs, 25–50 nm) as antigen- or adjuvant-carriers. The antigen carrier function of PEG-b-PLGA NPs was compared against an experimental benchmark polystyrene nanoparticles (PS NPs, 40–50 nm), both conjugated with the model antigen ovalbumin (OVA-PS NPs, and OVA-PEG-b-PLGA NPs). The OVA-PEG-b-PLGA NPs induced sustained antibody responses to Day 120 after two immunizations. The OVA-PEG-b-PLGA NPs as a self-adjuvanting vaccine further induced IL-4 producing T-helper cells (Th2), but not IFN-γ producing T-cells (Th1). The PEG-b-PLGA NPs as a carrier for CpG adjuvant (CpG-PEG-b-PLGA NPs) were also tested as mix-in vaccine adjuvants comparatively for protein antigens, or for protein-conjugated to PS NPs or to PEG-b-PLGA NPs. While the addition of this adjuvant NP did not further increase T-cell responses, it improved the consistency of antibody responses across all immunization groups. Together these data support further development of PEG-b-PLGA NPs as a vaccine carrier, particularly where it is desired to induce Th2 immunity and achieve sustained antibody titers in the absence of affecting Th1 immunity.Keywords
Funding Information
- National Institutes of Health (R01AI144609, R21AI133533)
- National Science Foundation (DGE174891)
This publication has 40 references indexed in Scilit:
- Particulate carrier systems as adjuvants for cancer vaccinesBiomaterials Science, 2019
- T cell-mediated immunity to malariaNature Reviews Immunology, 2019
- A Synthetic Nanoparticle Based Vaccine Approach Targeting MSP4/5 Is Immunogenic and Induces Moderate Protection Against Murine Blood-Stage MalariaFrontiers in Immunology, 2019
- Critical size limit of biodegradable nanoparticles for enhanced lymph node trafficking and paracortex penetrationNano Research, 2019
- Malaria vaccines in the eradication era: current status and future perspectivesExpert Review of Vaccines, 2019
- Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8+ T Cell ResponsesFrontiers in Immunology, 2018
- T helper 2 and T follicular helper cells: Regulation and function of interleukin-4Cytokine & Growth Factor Reviews, 2016
- The Use of Synthetic Carriers in Malaria Vaccine DesignVaccines, 2015
- T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 productionCytokine, 2015
- B cells responses and cytokine production are regulated by their immune microenvironmentCytokine, 2015